In cisplatin-induced AKI, ERK plays a crucial role in inflammation and apoptosis, shown by an increased level of phosphorylated ERK1/2 and an increase in the p53 and Bax expression along with the caspase-3 activation [111]. Here, TP53 is linked to acute kidney injury.